Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Seralutinib - Gossamer Bio

Next Previous
X
Search
Drug Profile

Seralutinib - Gossamer Bio

Alternative Names: GB-002; PK-10571

Latest Information Update: 05 Dec 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator YM BioSciences
  • Developer Gossamer Bio
  • Class Amides; Pyrazines; Pyridines; Small molecules
  • Mechanism of Action Macrophage colony stimulating factor inhibitors; Platelet-derived growth factor alpha receptor antagonists; Platelet-derived growth factor beta receptor antagonists; Proto-oncogene protein c-kit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Pulmonary arterial hypertension
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Pulmonary arterial hypertension

Most Recent Events

  • 02 Dec 2024 Pulmokine has been acquired by XOMA
  • 17 May 2024 Efficacy and adverse events data from a phase II OLE trial in Pulmonary arterial hypertension presented at the 120th International Conference of the American Thoracic Society (ATS-2024)
  • 06 May 2024 Chiesi Farmaceutici enters into a global collaboration and license agreement with Gossamer Bio for the development and commercialization of seralutinib

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top